avidresearch @avidresearch
Joined October 2009-
Tweets26K
-
Followers10K
-
Following1K
-
Likes43K
First disease modifying and first RNAi editing drug now enrolling AATD participants and market is like MEH. $WVE
First disease modifying and first RNAi editing drug now enrolling AATD participants and market is like MEH. $WVE
Hopefully we finally get good data for IO beyond Pd1s. IO in cold tumors is a huge unmet need.
Pan-her2. This drug is incredible.
Pan-her2. This drug is incredible.
Damn! Finally $PRME is no longer a lab and is now in clinical trials.
Damn! Finally $PRME is no longer a lab and is now in clinical trials.
Weirdly is this good for $gern? Not directly related but it will be in heme space.
Weirdly is this good for $gern? Not directly related but it will be in heme space.
Interesting to see if other IL-2 players will move. IO space valuation completely subdued (rightful so after all the targets that went dud).
Interesting to see if other IL-2 players will move. IO space valuation completely subdued (rightful so after all the targets that went dud).
Interesting move! No discount... at a price of CA$1.95 per share $MDNAF $MDNA.to Medicenna Therapeutics Announces CA$20 Million Investment from RA Capital Management globenewswire.com/news-release/2…
Two exciting studies out in @Nature show that high tumor PGE2 limits IL-2 sensing and antitumor function in TIL. Disrupting this axis can potently enhance antitumor responses. Nice work @CoukosGeorge @JBoettcherLab and teams! nature.com/articles/s4158… nature.com/articles/s4158…
IL-2 been dead after $NKTR disaster (market reaction to IL2 been nada). Plenty of companies trying for next gen IL-2. Some data from PROCLAIMSM national patient registry pointing to potential synergies of a safe and effective IL-2 with PD1. $MDNAF $HOWL $XLO
Opdualag Lag-3 almost a blockbuster based on just one indication (melanoma). Data from NSCLC overdue. Hopefully we see it soon. $BMY
Anyone seen $BMY lag-3 data for NSCLC. They indicate POC achieved.
Anyone seen $BMY lag-3 data for NSCLC. They indicate POC achieved.
Always thought moon shot was all hype but what this man has done for undruggable RAS/KRAS targets (30% of all cancers) makes me optimistic about the moonshot.
Always thought moon shot was all hype but what this man has done for undruggable RAS/KRAS targets (30% of all cancers) makes me optimistic about the moonshot.
$BMY overpaid. KRAS landscape changing rapidly.
$BMY overpaid. KRAS landscape changing rapidly.
Hope this is a double top !
Landscape of KRASG12C, Associated Genomic Alterations, and Interrelation With Immuno-Oncology Biomarkers in KRAS-Mutated Cancers [Mar 23, 2022] @SalemGIOncDoc et al. @JCOPO_ASCO ow.ly/PpPS50IK2QH #ImmunoOnc #PrecisionMedicine
$DAWN great drug. Front line study design (sample size) could be updated per management comments recently. Any clarity on that and the probability of success for frontline likely needed for M&A prospects.
#ASCO24 Abstract Titles, including LBAs, Released online: April 24, 2024, at 10:00 AM (ET)
Interesting new IO target? CCR8.
A sharp look at an emerging onco niche we're likely to hear much more about going forward - who will be the fortunate ones? bit.ly/3w1KsVD
Pharmdca @Pharmdca
90K Followers 141 Following USC Pharmacy Alumni, Full Time Investor. My tweets are a general reflection of where Iam investing money and not a recommendation. Please do your due diligence.
Brad Loncar @bradloncar
69K Followers 365 Following #Biotech, Founder of @BiotechTVHQ, KC native, @univmiami hurricane.🧬🙌
Adam Feuerstein ✡�.. @adamfeuerstein
114K Followers 750 Following Reporter @statnews. The Harry Kane of biotech. Dog ❤️er. Polk Award winner. #COYS. Said one analyst: The likes of Adam Feuerstein attack viciously.
dough @semodough
37K Followers 568 Following BIOTECH man LONGTERM FOCUS many positions-also trade around my CORE holdings my opinion only do your own research with me
Bio Stocks™ @BioStocks
65K Followers 84 Following Investor/trader focused primarily in the biopharma sector. Tweets are not investment advice and are not recommendations of any kind.
Dirk Haussecker @RNAiAnalyst
18K Followers 508 Following There are no alternative truths. Please do not allow evil to spread and destroy our freedom of life. Not investment advice
Persimmon Tree Invest.. @PersimmonTI
8K Followers 182 Following “The fault, dear Brutus, lies not within the stars, but in ourselves, that we are underlings.”
Jacob Plieth @JacobPlieth
26K Followers 285 Following Journalist @ ApexOnco. The Wolverine Of Biotech / Mr ASH. Once had a blue tick. Interested in: oncology. Not interested in: what stock you bought today.
Jonathan Faison @jfais20
8K Followers 274 Following Founder of 500+ member ROTY Biotech Community. Focus on accelerating clinical & commercial momentum. Learning from my highs and lows, add value where I can
Dan Rosenblum @sharkbiotech
23K Followers 1K Following Trading with the sharks at sharkinvesting since 1999 . Writing about biotech since 2006.
Kaushik @BigBullCap
89K Followers 536 Following Sharing For Informational Purpose Only | No Investment Advice | Our Discord Community https://t.co/ArPBW919KR
HODOR @Maximus_Holla
44K Followers 1K Following Swing & day trader Tweets are my opinion only and not a recommendation to buy or sell any security. Parody account!
Biotech Jim @JamesEKrause
11K Followers 548 Following phd biochem, not ichthyol; prof neurobiol, biotech entrepreneur, neurogeek, inventor, environmentalist focused on sustainability, also ERoEI. #neurosteroids
Jordan Alexander @JD4for4
7K Followers 298 Following LT investor looking for 5-10x upside over 3-5 years. Tweets are my own opinions & not investment advice.😘👰👦🧒👶
Professor Oak @Prof_Oak_
8K Followers 651 Following Biopharma Musings | Genetic Medicine & Rare Disease | Buyside Turned Operator | Not Investment Advice | DYODD
Matthew Gamber @MattBiotech
4K Followers 201 Following New writing out on April 30, 2024. Sign up at link at bio.
Drugs @drug_smolecules
7K Followers 565 Following ☣Femtomolar potency poems and limericks ☣Oceanic Boundlessness (p=0.0001)
Pharmdca @_Pharmdcaa
18 Followers 482 Following USC Pharmacy Alumni, Full Time Investor. My tweets are a general reflection of where Iam investing money and not a recommendation. Please do your due diligence.
nextbigtrade @NeextbiggTrade
1K Followers 4K Following Trading High Potential Stocks Using Stage Analysis Premium Newsletter: https://t.co/M92OOLldSc
CharlyFFM @Charly_FFM
147 Followers 921 Following Investor with background in IB (CFA) & Life Science industry
knotty rod @knotty_rod
121 Followers 180 Following
Trader Z @1TraderrZ
63 Followers 1K Following Hybrid day/swing trading strategy. Proper Preparation Prevents Piss Poor Performance. EDUCATIONAL THEORY ONLY! NOT INVESTMENT ADVICE! #trading #stocks #nasdaq
Farederick @Farederick65565
29 Followers 631 Following welcome every One 🔥🔥 we have best iptv subscription 🔥🔥 https://t.co/S0gFooBlw7 All world wide uk /USA service available with 190000+ live chanel 8000+
MidasBull⚡ @MidasBull
349 Followers 2K Following #Freedom🕊️#Liberty🗽#Longevity🌱#AntiAging🧬#Biohacking🧬#Science🔬#Neuroscience💡#Brain🧠#Nootropics💊#Biotech🧪#Trading📊#Stocks📈#MartialArts🥋
Science Saves @scisaves
65 Followers 397 Following
Nicole G @g_nab_87
11 Followers 219 Following
Jorge Financial @Tomas8Jorge
581 Followers 7K Following Investments, Stock Exchange, Dividends, Portfolio Management, Dividend Growth, Business, Passive Income, Value Investing
yogesh mishra @yogeshontherock
36 Followers 311 Following
Nick G @NikoG1211
92 Followers 610 Following Passionate about music, overanalyzing Chicago sports, and bringing new cancer diagnostics and treatments to patients
lychee and pishi @zoom236
6 Followers 348 Following
Ankur @ankurs85
9 Followers 159 Following
Willie Ray Vals @HcWrv
18 Followers 149 Following Healthcare / Pharma / Biotech | Graduated School of Hard Knocks
Phil Hyde @philhyde_
547 Followers 835 Following Full-Time Trader #stock Trader | Author | I help traders gain mental and technical edge in the financial markets.
Craig Lassiter @Craig_lassiter5
65 Followers 518 Following Class of 2028 I 100M Runner Pr 11.7 l 200M 24.5 l Raleigh nc l RBMSl Email:[email protected] l 3 Sport🏀🏈🏃🏾♂️ My goal is to run 10.8 in 9th grade!
Callaway Kid @CallawayKi91134
1 Followers 45 Following
ClarisCastaldo @CastaldoCl99351
2 Followers 780 Following
Long @longbios
13 Followers 137 Following former buy / sell side currently biotech exec + bio investor
Jacob Thompson @Jacob1Thompson
355 Followers 6K Following Stock | Futures | Crypto technical trader using various TA strategies | Tweets are opinions not FA
Armin @arminla
252 Followers 2K Following
RichardMoglen @RichardMoglen77
196 Followers 4K Following Stock Trader & Student of the Markets • I help traders improve their systems & performance at @TraderLion & @Deepvue.sharing Lesson from 100+ Marke wizard
Dogtor @Dogtor01416800
420 Followers 135 Following Addiction to loosing money on daily biotech 🧬 gamble 🎰 can't be treated at the urrent stage of scientific development.
Andrew @Andrew87425884
3 Followers 25 Following
Florida Man @aplumbob
129 Followers 379 Following
eugene🖖🏼🧬 @redshirtet
617 Followers 5K Following live long and prosper (but life is short). shit happens. let it rip (and carpe diem). i have nothing to add.
Nelson Dusetti 🇫�.. @NelsonDusetti
2K Followers 4K Following Translational research in pancreatic cancer - @crcm_marseille - INSERM U1068
Luke McLaughlin @LKMBiotechRev
50 Followers 906 Following Biotech Digital Marketer, Business Developer and Life Science Content Creator Founder of Biotechnology reviews Journal Biotech Communication Journal
Katelyn Rodriguez @KatelynRod92653
61 Followers 624 Following No matter how bad you think your life is, it's someone else's fairy tales. Give thanks for what you have.
Catherine Novack @catnova24
3 Followers 424 Following
Brian G @alpha1charts
192 Followers 7K Following Catch the big trends & keep it simple. Engineer, CFA (but CMT at heart). Entered markets in '99. StockTwits since '11. Not investment advice.
Erica Lee @eblee113
118 Followers 574 Following MD PhD student at Johns Hopkins focused on improving motor and sensory outcomes after peripheral nerve injury. Loves bourbon, boba, cats, and coffee ☕️
name @taiwan_vu
11 Followers 756 Following
@madeintheUSA @madeintheUSA0
187 Followers 2K Following
Jonny_fun_guy @Jonny_fun_guy
258 Followers 921 Following A good time is collecting fat from a liposuction clinic and rendering while adding lye and using it to post on Twitter.
Mosaik News @mosaikHQ
807 Followers 358 Following Stay ahead of the curve with trending news delivered in real time. Stay Informed. Stay Ahead. We gather the pieces, you get the power.
Bill Goldfarb @GoldfarbBill
28 Followers 70 Following
Poorna Kannan @poorna1309
13 Followers 118 Following
Primary Midpoints @PrimaryMidpoint
2 Followers 15 Following Bio and tech. Only looking for the best clinical trial endpoints. Keep that mid ish away.
Dill @ThesleeplessT
527 Followers 2K Following ***Prop Trader***Python Developer*** Obsessed with economics and data visualizations and analysis 💹♻️*** Not financial advice 📄
Vold @ZenVold
14 Followers 83 Following
Pharmdca @Pharmdca
90K Followers 141 Following USC Pharmacy Alumni, Full Time Investor. My tweets are a general reflection of where Iam investing money and not a recommendation. Please do your due diligence.
Brad Loncar @bradloncar
69K Followers 365 Following #Biotech, Founder of @BiotechTVHQ, KC native, @univmiami hurricane.🧬🙌
Adam Feuerstein ✡�.. @adamfeuerstein
114K Followers 750 Following Reporter @statnews. The Harry Kane of biotech. Dog ❤️er. Polk Award winner. #COYS. Said one analyst: The likes of Adam Feuerstein attack viciously.
Bertrand Delsuc @BertrandBio
16K Followers 253 Following Views=mine only, RT-like=/=endorse, no advice. 16y in Tech (chip design) & a bit of Bio :)
dough @semodough
37K Followers 568 Following BIOTECH man LONGTERM FOCUS many positions-also trade around my CORE holdings my opinion only do your own research with me
Bio Stocks™ @BioStocks
65K Followers 84 Following Investor/trader focused primarily in the biopharma sector. Tweets are not investment advice and are not recommendations of any kind.
Dirk Haussecker @RNAiAnalyst
18K Followers 508 Following There are no alternative truths. Please do not allow evil to spread and destroy our freedom of life. Not investment advice
Persimmon Tree Invest.. @PersimmonTI
8K Followers 182 Following “The fault, dear Brutus, lies not within the stars, but in ourselves, that we are underlings.”
Jacob Plieth @JacobPlieth
26K Followers 285 Following Journalist @ ApexOnco. The Wolverine Of Biotech / Mr ASH. Once had a blue tick. Interested in: oncology. Not interested in: what stock you bought today.
Sports_Bios @Sports_bios
11K Followers 89 Following
Jonathan Faison @jfais20
8K Followers 274 Following Founder of 500+ member ROTY Biotech Community. Focus on accelerating clinical & commercial momentum. Learning from my highs and lows, add value where I can
Dan Rosenblum @sharkbiotech
23K Followers 1K Following Trading with the sharks at sharkinvesting since 1999 . Writing about biotech since 2006.
Kaushik @BigBullCap
89K Followers 536 Following Sharing For Informational Purpose Only | No Investment Advice | Our Discord Community https://t.co/ArPBW919KR
HODOR @Maximus_Holla
44K Followers 1K Following Swing & day trader Tweets are my opinion only and not a recommendation to buy or sell any security. Parody account!
Biotech Jim @JamesEKrause
11K Followers 548 Following phd biochem, not ichthyol; prof neurobiol, biotech entrepreneur, neurogeek, inventor, environmentalist focused on sustainability, also ERoEI. #neurosteroids
Professor Oak @Prof_Oak_
8K Followers 651 Following Biopharma Musings | Genetic Medicine & Rare Disease | Buyside Turned Operator | Not Investment Advice | DYODD
Matthew Gamber @MattBiotech
4K Followers 201 Following New writing out on April 30, 2024. Sign up at link at bio.
Drugs @drug_smolecules
7K Followers 565 Following ☣Femtomolar potency poems and limericks ☣Oceanic Boundlessness (p=0.0001)
Brice Foose @PharmDFoose
2K Followers 141 Following Trader - Seven Points Capital - Posts are not recommendations to Buy or Sell. Disclosure: https://t.co/ED76dI6nyr - PRN/PT Retail Pharmacist
Jeff Cranmer @jeff_cranmer
3K Followers 1K Following Executive Editor, @BioCentury. Jersey boy happily ensconced in Cali. Dad. Failed poet. Devoted Iggles fan. Cats. @Princeton, @SAISHopkins alum. Opinions? Mine.
Kyle @kyletrades_
3K Followers 28 Following US Equity swing trader | Sharing my journey - nothing should be taken as advice.
NCDC @NCDCgov
1.2M Followers 393 Following The official Twitter account of the Nigeria Centre for Disease Control and Prevention (NCDC) || Social Media Policy: https://t.co/atAH0s6OEF || Toll-free: 6232
Alex O'Neill @AlgoTradingGuy
291 Followers 473 Following Ex-Pro trader, ditched the grind to live on my terms. Building algo trading SaaS for automated income & freedom. Sharing how to break free from the screens.
IASLC @IASLC
19K Followers 2K Following The International Association for the Study of Lung Cancer is the only global organization dedicated solely to the study of lung cancer. #LCSM
Algomatic Trading @AlgomaticTrade
2K Followers 3K Following Swedish Systematic Trader | 100% Systematic | Developing Multi-Strategy Portfolios
M T @illium51
20 Followers 30 Following
Carlos Gatón @gaton_carlos
29 Followers 62 Following
Salar Roshan @whitemtnbiotech
246 Followers 233 Following Biotech VC. Drug hunter. Opinions are my own.
Ingo Hartung @HartungIngo
14K Followers 780 Following MedChem @Merckgroup; drug discovery nerd in oncology, immunology & targeted protein degradation, soccer, politics or tapas can get into the way; my own views
Biotech Investor @learnbiotech
2K Followers 307 Following Learn to invest in biotech like the professionals from a former biotech executive and investment banker Course on Thinkific
Robert Sun @RobertSun24
10K Followers 10K Following Inventor of 24® game and @FirstInMath online. Engineer, Social entrepreneur, TEDx speaker, contributor to Huffington Post, London Economic, NCSM, EdTech Times
First In Math @FirstInMath
3K Followers 1K Following First In Math® is an online math program from the makers of the 24® Game - Energizing Every Child to Learn, Love & Live Math™ #education #distancelearning #math
Waggy @WagsCapitalLLC
39 Followers 48 Following Hate my job love my people. Fintwit and Life Sciences banter. Warehouse Enthusiast.
Luciano Santollani @LSantollani
576 Followers 447 Following Biotech startups @PetriBio @Pillar_VC | PhD candidate @MIT, Irvine + Wittrup Labs | @Stanford '18
value @ValueForAll1
225 Followers 470 Following Biotech Investor. Not an investment advice, do your due diligence.
Tech Fund @techfund1
5K Followers 859 Following Early $NVDA $ASML $AMZN $META etc investor, among many others. Long-term tech investor. Helped oversee $20bn for 15 years, now retired.
Paul Bolno @PaulBolno
149 Followers 75 Following
Bubba @AConfidenceGame
292 Followers 477 Following It’s only money, until you pull out your wheelbarrow to pay your landlord.
Drug hunter @ShangYonglei
51 Followers 313 Following Life scientist, antibody and large molecule therapeutics development
Jones Allen @jonesallen236
43 Followers 22 Following Blazing a trail of independent thought while looking for a few good investments in biotech and technology.
Daphne Zohar @daphnezohar
22K Followers 886 Following Founder & CEO of @SeaportTX. Founding CEO & now Senior Advisor @PureTechH. I share biotech news & commentary. Co founder/host @BiotechCH. Board @IamBiotech
Tom Hartman @sacredprofit
118 Followers 171 Following Creator of The Sanctum, a premium indicator library for TradingView.
AnnemiekeAartsma-Rus @oligogirl
3K Followers 486 Following Translating science from bench to bedside and from jargon to lay language
JediBiotech @JediBiotech
111 Followers 177 Following Current physio, father of 3 boys, husband to an amazing wife, avid Tottenham fan, and trader of biotech. Not advice just my musings.
Banana Oncology @Banana_Oncology
249 Followers 232 Following - Academic/Pharma veteran - Oncology & I/O - Identifying asymmetric bets through scientific/financial deep dives - Not financial advises - Here to learn
IC50 Cent @IC50_cent
116 Followers 286 Following
KAY KIM @2kaykim
19K Followers 45 Following Options/Leveraged ETF/Crypto-Miner Trader, Securities Investor, Technical Analyst, Founder of @2TradersClub (Est. 2012*)
Jelena_Immunology @immunoinvest
116 Followers 298 Following
Perry Rod @Perryhrod
660 Followers 87 Following From Philosopher 🤔 to Musician 🎸 to Retail degenerate investor 💎🙌 to hedge fund manager ⚡️ 💀 ⚡️ Nothing I share is investment advice
Jake Weber @BioStockAnalyst
4K Followers 734 Following Biotech stock analyst. Editor of Biotech Millionaire at Mauldin Economics. Tweets and opinions are not investment advice.
The Goose @CryptoGoo5e
2K Followers 304 Following 10+ years of equity trading. I tweet about day trading, crypto, video games - and sometimes hockey. Any tweets are not financial advice.
Cognivestment @cognivestment
52 Followers 50 Following
Lord_of_Biotechs @Lord_of_Biotech
1K Followers 177 Following The one to subjugate all shabby biotechs | German Biotech and Special Situation enthusiast |
Mark @Mark748779211
61 Followers 100 Following Math PhD | Economics | Biotech | Golf | Parenting as a Millennial | Stupidity of American Politics
Pete @petertrades
18K Followers 491 Following Stocks & Options gambler. Tweets and posts are not investment advice.
Steven Spencer @sspencer_smb
38K Followers 3K Following prop trader in nyc. focus is intra-day&swing. long term $TSLA shareholder.
Marios Stamatoudis @stamatoudism
11K Followers 194 Following 2023 US Investing Championship - Top Performer | Momentum Trader | Here to Share & Help
Oncinvestor @oncinvestor
197 Followers 123 Following cancer survivor, biotech investor, tweets are my thoughts- not financial advice. Always do your own research. Tulip szn is the best szn.
Market Scholars @MarketScholars
5K Followers 482 Following Knowledge📘 Application✏️ Community👥 Stocks & Options Trading Rooms for serious investors @davidsettle42 & @BrandonVanZee https://t.co/DCDnR8yDEg
Goverdhan Gajjala @gov_gajjala
22K Followers 116 Following 2023 US Investing Championship Winner. Learning & Sharing about Momentum Trading in @MMT_Access. Beware of impersonators.
Dividend Dynasty @DividendDynasty
13K Followers 652 Following Will - 24 Year Old 🇬🇧 MBA. Tracking & sharing my personal finance journey 📈. I like quality businesses that pay dividends but view them as a last resort.
The Secrets of Life @DSecretsOfLife
321K Followers 58 Following Become the best version of yourself. DM to boost your brand.
@avidresearch @JacobPlieth Gotcha, I would caution on this — none are primary PD-1 resistant responses which makes the pop quite heterogenous in re-treatment benefit, and small n=2/6. MK-4830 ILT4 had cORR (5/11) in PD-1 experienced, unlikely it was reproduced—silence since.
Unclear on when reads out given its event driven but IgG4-RD trial (“MITIGATE”) very interesting as well. Huge unmet need there ncbi.nlm.nih.gov/pmc/articles/P… clinicaltrials.gov/study/NCT04540… $AMGN $ELYM $CGEM
There are TWO Phase 3 trials for CD19 mAb inebilizumab in autoimmune disease reading out 𝑻𝑯𝑰𝑺 𝒀𝑬𝑨𝑹 MG classic.clinicaltrials.gov/ct2/show/NCT04… SSc classic.clinicaltrials.gov/ct2/show/NCT05… I expect SSc to work. MG tougher call for me. $AMGN $ELYM $CGEM
$LLY has bad structured pipeline. To fix thet they may need to buy early stage companies with novel technologies I have a few suggestion to help them $RVMD (RAS ON) $NUVL (ROS, ALK) $KYMR (TPD) Other suggestions welcome
@BowTiedBiotech Wouldn't be surprised to see them buying early stage companies with novel technologies like $RVMR (RAS ON) $NUVL (ROS, ALK), $KYMR (TPD) or all of the above🙂
$CUE (<$50m EV) also has an anti-CD19 TCE program they suggest has distinctive advantages over $ELYM $CABA and $CGEM 🤔 Maybe we'll get an update with their upcoming Q1 results?
$ELYM > or = $ALPN in PMN?! very small n obvi but just sayin nice initial data from $ELYM with PMN update later this year... non cell tx* CD19 I&I is 🔥🔥🔥 *emphasis on non cell tx, pls stop w/ this. thx.
$LBPH TAM 6B They has 58% seizure reduction better than competitors (Fintepla - $UCB, Epidiolex - $JAZZ) LBPH MC is 840M cash 270M Last capital raise in Jan at $21 Relevant acquisitions in the field JAZZ - GW $7.2B PFE - ARNA $6.7B UCB - ZGNX $1.9B 5x is reasonable return IMO
$LBPH Baird PT 36 DEE epilepsy. Ph 2 completed successfully To start Ph 3 in H2 Plus OLE data in H2
$LYRA -- Phase 3 Results from ENLIGHTEN 1 Trial of LYR-210 in Chronic Rhinosinusitis (CRS) Expected in May -- investors.lyratherapeutics.com/news-releases/…
Figure 21B seems to be the killer figure. The crosslinking PSMA mAb variant is 1000x more potent than the non-cross linking mAb.
Here is the cool covalent cross linking mAb platform. First patent is here. FSY seems to be the covalent linker target receptor. Super cool idea. patents.google.com/patent/WO20232…
Incubated by Avalon Ventures, 3 y.o. San Diego biotech Enlaza is heading toward the clinic with $161M in funding & a platform with which it could create the 1st covalent biologic drugs. @BioBonanos speaks with CEO Sergio Duron in @BioCentury
This CD19 revival reminds me of $VERA Atacicept around for a long time. Small trial with idiosyncratic (and ultimately just unlucky) tox signals caused pessimism and doubt about utility. Inebilizumab likely a very good therapy, but pigeon holed early. $elym $cgem
Unpopular opinion, but I don’t think the muscle saving obesity drugs will do well. If you’re not losing muscle, you’re not losing as much weight. I understand the concept, but I believe it will be a tough sell to convince people that losing less weight is the better option.
60 Minutes $NVDA Jensen Huang youtube.com/watch?v=DpQQi2…
For IPF, missing @PrezCamacho's company Endeavor. ENV-101 in phase 2. endeavorbiomedicines.com/our-science/pi…
IPF and depression landscapes from GS' initiation report on $CTNM
$BBIO MGT remained optimistic acoramidis would be able to make significant inbounds, reaching multi-billion in peak sales potential.
HOTKEYS AND THE COST OF PRICE SLIPPAGE A few times now it has come up how critical hotkeys were to my trading. Many were astounded to learn that I virtually never used the mouse bc of how slow it is. Many of the replies have made the argument that hotkeys aren’t relevant to…
More evidence of a big downward correction for value of Ivy League degrees. Other private schools aren't simialry affected. x.com/johnarnoldfndt…
Now confirmed with data. Forbes surveyed managers with hiring authority. When asked whether more/less likely to hire vs 5 years ago: Ivy League: 7% more likely; 33% say less likely Public univs: 42% more likely; 5% less likely Selective privates: 37% more likely; 5% less likely
$prme not really surprised by regulatory success here. David Liu and Marks have been having a platonic love affair ♥️ endlessly cross-referencing each other at conferences. What Prime is hoping for is that 1 IND can be used as a platform template for future filings. US…
No doubt and thanks for the shoutout Lance. If I had an hour I would’ve used it in Vegas but the premise was that hotkeys indeed are an advantage that people sleep on. It’s very clear for people with gaming backgrounds (@TheOneLanceB used to play Dota also!) because you could…
HOTKEYS AND THE COST OF PRICE SLIPPAGE A few times now it has come up how critical hotkeys were to my trading. Many were astounded to learn that I virtually never used the mouse bc of how slow it is. Many of the replies have made the argument that hotkeys aren’t relevant to…
Big 3-6 months ahead for us at @TradeZella - doubling our engineering team (our team right now with current growth is extremely small, and i didn’t plan properly for this) - massive updates/ improvements to the backtesting feature - new reports/ insights being worked on -…
We haven't seen $AAPL reaching 'extreme oversold' level like this since 2019
Trends for United States
You might like
